Cargando…

A 3D Monte Carlo Method for Estimation of Patient-specific Internal Organs Absorbed Dose for (99m)Tc-hynic-Tyr(3)-octreotide Imaging

Single-photon emission computed tomography (SPECT)-based tracers are easily available and more widely used than positron emission tomography (PET)-based tracers, and SPECT imaging still remains the most prevalent nuclear medicine imaging modality worldwide. The aim of this study is to implement an i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Momennezhad, Mehdi, Nasseri, Shahrokh, Zakavi, Seyed Rasoul, Parach, Ali Asghar, Ghorbani, Mahdi, Asl, Ruhollah Ghahraman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809152/ https://www.ncbi.nlm.nih.gov/pubmed/27134562 http://dx.doi.org/10.4103/1450-1147.174700

Ejemplares similares

Specific Absorbed Fractions of Internal Photon and Electron Emitters in a Human Voxel-based Phantom: A Monte Carlo Study
por: Asl, Ruhollah Ghahraman, et al.
Publicado: (2017)

Patient-specific dosimetry of (99m)Tc-HYNIC-Tyr(3)-Octreotide in children
por: Hou, Xinchi, et al.
Publicado: (2017)

Evaluation of [(99m)Tc][Tc-HYNIC/EDDA]-Tyr as a target for metabolic tumor imaging in B16F10 melanoma tumor
por: Yaghoubi Mogadam, Hemat, et al.
Publicado: (2022)

(99m)Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
por: Liepe, Knut, et al.
Publicado: (2018)

Clinical usefulness of (99m)Tc-HYNIC-TOC, (99m)Tc(V)-DMSA, and (99m)Tc-MIBI SPECT in the evaluation of pituitary adenomas
por: Vukomanovic, Vladimir R., et al.
Publicado: (2019)

Clinical validation and diagnostic accuracy of (99m)Tc-EDDA/HYNIC-TOC compared to (111)In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study
por: Moriguchi-Jeckel, Cristina M, et al.
Publicado: (2023)

Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

(99m)Tc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency
por: Kotzerke, Joerg, et al.
Publicado: (2014)

A novel molecular imaging probe [(99m)Tc]Tc-HYNIC-FAPI targeting cancer-associated fibroblasts
por: Jiang, Yanghongyan, et al.
Publicado: (2023)

Monte Carlo Study of the Effect of Collimator Thickness on T-99m Source Response in Single Photon Emission Computed Tomography
por: Islamian, Jalil Pirayesh, et al.
Publicado: (2012)

(99m)Tc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies
por: Schaper, Frédéric L.W.V.J., et al.
Publicado: (2013)

Value of Somatostatin Receptor Scintigraphy with (99m)Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
por: Anzola, Luz Kelly, et al.
Publicado: (2019)

Author Correction: Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

Diagnostic accuracy of (99m)Tc-HYNIC-TOC SPECT/CT for detecting osteomalacia-associated tumors
por: Li, Bo, et al.
Publicado: (2023)

Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of (99m)Tc-Hynic-rh-Annexin V Imaging
por: Kartachova, M.S., et al.
Publicado: (2008)

In-Vivo Biodistribution and Safety of (99m)Tc-LLP2A-HYNIC in Canine Non-Hodgkin Lymphoma
por: Zwingenberger, Allison L., et al.
Publicado: (2012)

Synthesis and Optimization of the Labeling Procedure of (99m)Tc-Hynic-Interleukin-2 for In vivo Imaging of Activated T lymphocytes
por: D’Alessandria, Calogero, et al.
Publicado: (2009)

A (99m)Tc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging
por: Shamshirian, Danial, et al.
Publicado: (2016)

(99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging
por: Ahmadpour, Sajjad, et al.
Publicado: (2018)

EDB Fibronectin-Specific SPECT Probe (99m)Tc-HYNIC-ZD2 for Breast Cancer Detection
por: Ye, Xiao-Xuan, et al.
Publicado: (2017)

Extraosseous Accumulation of Technetium-99m-Methyl Diphosphonate ((99m)Tc-MDP) in a Child with ALL: A Case Report
por: Banezhad, Farnaz, et al.
Publicado: (2018)

Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
por: Asl, Rohollah Ghahraman, et al.
Publicado: (2021)

Evaluation of (99m)Tc-HYNIC-βAla-Bombesin((7-14)) as an agent for pancreas tumor detection in mice
por: Carlesso, F.N., et al.
Publicado: (2015)

(99m)Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study
por: Lambert, Bieke, et al.
Publicado: (2016)

Multiple Cutaneous Metastases on (99m)TC-HYNIC-TOC Scan in a Rare Case of Malignant Laryngeal Paraganglioma
por: Sankar, Gowri, et al.
Publicado: (2018)

Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC
por: Xiao, Zunyu, et al.
Publicado: (2017)

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022)

The impact of (177)Lu-octreotide therapy on (99m)Tc-MAG3 clearance is not predictive for late nephropathy
por: Werner, Rudolf A., et al.
Publicado: (2016)

Jaffe–Campanacci syndrome: Any role for (99m)Tc-methylene diphosphonate bone and (99m)Tc-octreotide scans for evaluation of the disorder?
por: Qutbi, Mohsen, et al.
Publicado: (2019)

In vivo(99m)Tc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation
por: Guo, Ming-fang, et al.
Publicado: (2009)

The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
por: Koçyiğit Deveci, Emel, et al.
Publicado: (2013)

Preparation and Bioevaluation of Novel (99m)Tc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia
por: Ruan, Qing, et al.
Publicado: (2021)

Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy
por: Li, Bo, et al.
Publicado: (2022)

SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis
por: Luo, Xiu, et al.
Publicado: (2023)

The efficacy of (99m)Tc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastasis in newly diagnosed prostate cancer
por: Wang, Taisong, et al.
Publicado: (2023)

(99m)Tc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy
por: Hoebers, Frank J. P., et al.
Publicado: (2007)

Evaluation of (99m)Tc-HYNIC-VCAM-1(scFv) as a Potential Qualitative and Semiquantitative Probe Targeting Various Tumors
por: Zhang, Xiao, et al.
Publicado: (2018)

(99m)Tc-HYNIC-IL-2 scintigraphy to detect acute rejection in lung transplantation patients: a proof-of-concept study
por: Telenga, Eef D., et al.
Publicado: (2019)

SPECT Imaging of SST2-Expressing Tumors with (99m)Tc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers
por: Gaonkar, Raghuvir Haridas, et al.
Publicado: (2021)

(99m)Tc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
por: Briganti, Vittorio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cagc35uu2vdehtb796f731de65